Deutsche Bank Reiterates Hold On Allscripts Healthcare Solutions (MDRX)

Deutsche Bank is reiterating its Hold rating and $19.50 price target on Allscripts Healthcare Solutions Inc MDRX, after it reported earnings yesterday. In a note sent to clients, Deutsche Bank writes, "MDRX's reported an in-line Q, with bookings coming above expectations. We note that MDRX is well positioned to benefit from the ARRA stimulus, and its recent closure of the Eclipsys transaction significantly expands its ability to provide an integrated offering spanning the hospital to community physician space. While bookings trajectory points to favorable trends for the company, a fair risk/reward profile causes us to reiterate our Hold rating." Shares of MDRX lost 13 cents yesterday to close at $19.36, a loss of 0.67%.